萊美藥業(300006.SZ):公司資產公開掛牌轉讓未徵集到意向受讓方
格隆匯3月30日丨萊美藥業(300006.SZ)公佈,公司於2020年3月22日通過重慶聯合產權交易所集團首次公開掛牌轉讓公司直接或間接持有的湖南康源製藥有限公司(“湖南康源”)100%股權、公司直接持有的四川禾正製藥有限責任公司(“四川禾正”)100%股權(含其全資子公司成都禾正生物科技有限公司、四川萊禾醫藥科技有限公司)、重慶萊美健康產業有限公司(“萊美健康”)60%股權和重慶萊美金鼠中藥飲片有限公司(“萊美金鼠”)70%股權(“標的股權”),截止2020年3月27日首次公開掛牌期滿,此次掛牌轉讓未徵集到意向受讓方。
公司結合市場將繼續在重慶產權交易網(網站地址:https://www.cquae.com)公開掛牌轉讓標的股權,掛牌條件與首次掛牌條件保持一致,此次掛牌公告期為2020年3月31日至2020年4月7日。
鑑於公司持有的成都金星健康藥業有限公司(“成都金星”)90%股權處置尚待取得其他少數股東的同意並放棄優先購買權,公司將擇機處置持有的成都金星90%股權;此次繼續公開處置標的股權是公司加速聚焦主業發展、避免與控股股東產生同業競爭的需要,公開掛牌轉讓標的公司股權順利完成後,標的公司將不再納入公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.